23. Reactions of nitrosoarenes with SH groups |
1039 |
174.C. Storle¨ and P. Eyer, Chem.-Biol. Interact., 83, 271 (1992).
175.S. Karreth and W. Lenk, Xenobiotica, 21, 417 (1991).
176.J. Suzuki, S. -I. Meguro, O. Morita, S. Hirayama and S. Suzuki, Biochem. Pharmacol., 38, 3511 (1989).
177.R. Heilmair, S. Karreth and W. Lenk, Xenobiotica, 21, 805 (1991).
178.R. H. Wilson, F. DeEds and A. J. Cox, Cancer Res., 1, 595 (1941).
179.J. W. Cramer, J. A. Miller and E. C. Miller, J. Biol. Chem., 235, 250 (1960).
180.F. A. Beland and F. F. Kadlubar, in Chemical Carcinogenesis and Mutagenesis. Handbook of Experimental Pharmacology, Vol. 94/I (Eds. C. S. Cooper and P. L. Grover), Springer-Verlag, Berlin, 1990, p. 267.
181.A. J. Varghese, Biochem. Biophys. Res. Commun., 112, 1013 (1983).
182. J. E. Biaglow, M. E. Varnes, L. Roizen-Towle, E. P. Clark, E. R. Epp, M. B. Astor and
E.J. Hall, Biochem. Pharmacol., 35, 77 (1986).
183.G. L. Kedderis and G. T. Miwa, Drug Metab. Rev., 19, 33 (1988).
184.A. J. Varghese and G. F. Whitmore, Int. J. Radiat. Oncol. Biol. Phys., 10, 1341 (1984).
185.A. J. Varghese and G. F. Whitmore, Chem.-Biol. Interact., 56, 269 (1985).
186.R. A. McClelland, R. Panicucci and A. M. Rauth, J. Am. Chem. Soc., 109, 4308 (1987).
187.J. L. Bolton and R. A. McClelland, J. Am. Chem. Soc., 111, 8172 (1989).
188.D. S. Noyce and G. T. Stowe, J. Org. Chem., 38, 3762 (1973).
189.P. Eyer and M. Ascherl, unpublished results (1984).
190.M. B. Noss, R. Panicucci, R. A. McClelland and A. M. Rauth, Biochem. Pharmacol., 37, 2585 (1988).
191.C. B. Brezden, R. A. McClelland and M. A. Rauth, Biochem. Pharmacol., 48, 361 (1994).
192.R. T. Mulcahy, J. J. Gipp, G. A. Ublacker, R. Panicucci and R. A. McClelland, Biochem. Pharmacol., 38, 1667 (1989).
193.J. J. Gipp, R. A. McClelland and R. T. Mulcahy, Biochem. Pharmacol., 42 (Suppl.), 127 (1991).
194.L. R. Berube, S. Farah, R. A. McClelland and A. M. Rauth, Biochem. Pharmacol., 42, 2153 (1991).
195.D. I. Edwards, Biochem. Pharmacol., 35, 53 (1986).
196.P. Goldman, R. L. Koch, T. -C. Yeung, E. J. T. Chrystal, B. B. Beaulie, M. A. McLafferty and
G.Sudlow, Biochem. Pharmacol., 35, 43 (1986).
197.W. J. Ehlhardt and P. Goldman, Biochem. Pharmacol., 38, 1175 (1989).
198. T. Sugimura, S. Sato and K. Wakabayashi, in Chemical Induction of Cancer, Vol. IIIC (Eds.
Y.-T. Lai, J. C. Arcos and M. F. Argus), Academic Press, San Diego, 1988, p. 681.
199.J. S. Felton, M. G. Knize, N. H. Shen, P. R. Lewis, B. D. Andresen, J. Happe and F. T. Hatch,
Carcinogenesis, 7, 1081 (1986).
200.J. S. Felton and M. G. Knize, in Chemical Carcinogenesis and Mutagenesis. Handbook of Experimental Pharmacology, Vol. 94/I (Eds. C. S. Cooper and P. L. Grover), Springer-Verlag, Berlin, 1990, p. 471.
201.G. A. Marsch, E. N. Goldman, E. Fultz, N. H. Shen and K. W. Turteltaub, Chem. Res. Toxicol., 8, 659 (1995).
202.K. R. Kaderlik, R. F. Minchin, G. J. Mulder, K. F. Ilett, M. Daugaard-Jenson, C. H. Teitel and
F.F. Kadlubar, Carcinogenesis, 15, 1703 (1994).
203.K. R. Kaderlik, G. J. Mulder, J. G. Shaddock, D. A. Casciano, C. H. Teitel and F. F. Kadlubar,
Carcinogenesis, 15, 1711 (1994).
204.R. Kato, Crit. Rev. Toxicol., 16, 307 (1986).
205.E. Wolz, D. Wild and G. H. Degen, Arch. Toxicol., 69, 171 (1995).